Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin).

Ther Adv Hematol · 2022 · PMC9218916 · PMID 35755297

Europe PMC DOI

hedged sentences

0.0100

closest p · 0.2× alpha

0.0100

boldest claim

The sentences

highly significantp < 0.01actually significant

Statistical differences were considered significant when p < 0.05 (*) and highly significant when p < 0.01 (**).

also in 132,142 other papers

borderline significantno p-value reported

Supplementary Table S6 and Figure 5 show the data obtained using RT-qPCR, which clearly demonstrates a borderline significant increase in γ-globin mRNA in ErPCs from sirolimus-treated patients.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.